Modelled Optimization of SARS-Cov-2 Vaccine Distribution: an Evaluation of Second Dose Deferral Spacing of 6, 12, and 24 weeks
GT Jurgens, K Lackner
doi: https://doi.org/10.1101/2021.02.28.21252638
GT Jurgens
unaffiliated
MDK Lackner
unaffiliated
MBAData Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Posted March 03, 2021.
Modelled Optimization of SARS-Cov-2 Vaccine Distribution: an Evaluation of Second Dose Deferral Spacing of 6, 12, and 24 weeks
GT Jurgens, K Lackner
medRxiv 2021.02.28.21252638; doi: https://doi.org/10.1101/2021.02.28.21252638
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12781)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4608)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (391)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4387)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (649)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6979)
- Radiology and Imaging (1538)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)